A synthetic peptide for use as a blocking control in assays to test for specificity of BLMH antibody, Alternative Names: BLMH control peptide, BLMH antibody Blocking Peptide, Anti-BLMH Blocking Peptide, Bleomycin Hydrolase Blocking Peptide, BH Blocking Peptide, BMH Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
BLMH
(Bleomycin Hydrolase (BLMH))
Hintergrund
The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B-aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity.